Lanean...
Single and Multiple Dose Pharmacokinetics of Dolutegravir in the Genital Tract of HIV Negative Women
BACKGROUND: Antiretrovirals (ARV) that achieve adequate concentrations in anatomical sites of transmission are of interest for HIV prevention. A Phase 1, open label, pharmacokinetic (PK) study was performed to describe first dose and steady-state PK of the integrase inhibitor dolutegravir (DTG) in b...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4038682/ https://ncbi.nlm.nih.gov/pubmed/23899439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2665 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|